Azilovact-3 Kit
The combikit of Fluconazole, Azithromycin, and Secnidazole tablets comes under the brand name Azilovact-3 Kit. It is a combination of medicines, which is prescribed for the management of vaginal and reproductive tract infections, including various conditions related to itching, irritation, and vaginal discharge. This combikit contains three ingredients that work together to eliminate the infection-causing microorganism.
Fluconazole is an antifungal medicine that prevents the growth of fungi. Azithromycin is a broad-spectrum antibiotic that fights bacterial infections. Secnidazole is an antiprotozoal and antibacterial agent that helps treat infections caused by parasites and anaerobic bacteria. By combining three medicines, this kit helps in treating different types of infections at the same time, relieving symptoms, and supporting faster recovery.
Common side effects may include:
Consult your doctor if any side effects persist or worsen.
Can this medicine cause stomach upset?
Yes, some of the people experience nausea, diarrhoea, and stomach pain; these are the side effect are usually mild.
Is this Combikit effective against viral infections?
No, this medicine works only against fungal, bacterial, and parasitic infections. It is not effective against viral infections such as the common cold or flu.
Can this Combikit be used for vaginal discharge?
Yes, it is commonly prescribed for vaginal discharge caused by mixed fungal, bacterial, or parasitic infections.
Can this medicine treat yeast infections?
Yes, Fluconazole in the combikit helps treat fungal infections caused by Candida species, commonly known as yeast infections.
Can I use this medicine during my menstrual period?
Follow your doctor’s instructions. In many cases, treatment can continue during menstruation unless advised otherwise.
| Brand Name | Azilovact-3 Kit |
|---|---|
| Composition | Combikit of Fluconazole Azithromycin and Secnidazole Tablets |
| Pack Size | 10 X 5 X 2 |
You must be logged in to post a review.
Reviews
There are no reviews yet.